Seen in downtown Athens. Had a good laugh. Somebody needs some PR advise.

An account to follow. Already 20 years in collaborative #TB #tuberculosis researh across Europe.

🆕⚡🧠HARVEST TRIAL:More Rifampin,Same Fate: High-Dose Rifampin Fails to Shift the Needle in TB Meningitis,NEJM,2025 Despite better theoretical CNS penetration,high-dose oral rifampin did not improve survival in adult TB meningitis & potential harm cannot be excluded #idsky www.nejm.org/doi/full/10....

A strange argument on energy consumption of data centers: "you need to have your data close by. We need to invest in more data centers" I do not need to hug my data. I just need storage in Europe. Efficient sharing instead of unlimited expansion. Energy and water consumption *is* an issue

Our yearly conference is about to start. Amsterdam Public Health research institute. #APH. Imporrant topic. Let's roll!!

We did a thing. 😬

This is a great opportunity. Come and work with us in this wonderful team.

TB deaths up 5% in 6 months since USAID funds pulled from Napula, Mozambique: #USAID #TBsky #TBFighters #tuberculosis observador.pt/2025/09/24/t...

#IDsky Unfortunately, despite a promising premise, Clofast did not pan out for shorter duration w/clofazamine rifapentine regimen (3 months) vs RIPE (6 mo). Shorter regimen had higher relapse rate, worsening radiographic response despite earlier cx conversion www.thelancet.com/journals/lan...

Today TAG launched some of our 2025 Pipeline Reports. You’ll find TB Treatment, along with all four HIV reports. Download them now! www.treatmentactiongroup.org/resources/pi...

A year after its breakout public health moment, 'miracle drug' lenacapavir has been approved by the FDA and recommended by the WHO. The drug is a long-lasting shot that provides almost 100% protection against HIV infection. buff.ly/E5zOvGl #ShareGoodNewsToo

The @who.int has prequalified the first African-made first-line #HIV treatment. Its procurement by @globalfund.bsky.social#HIVmarks progress in building resilient, self-sufficient health systems in Africa —still home to 65% of the global HIV burden. 🟠 https://f.mtr.cool/bdqvnetetr #GlobalHealth

With the #jpiamr program closing, there is a final conference on its achievements. Nice gathering of funders, scientists of all walks, and policy makers. Lessons learned when moving to EU partnership OneHealth. Looking forward to new era.

Great post. As always. Thanks

Crowds are different. The anger is the same. Tembi 2 years after the train crash. #τεμπι.

The Dutch gvt joins the move to shortsightedness. "Development aid only for projects with direct returns for the Netherlands". Exit sexual health, women partcipation, and climate. #development #aid #RSH. A sad day for many

The WHO research agenda for #AMR in human health has identified 40 research priorities to be addressed by 2030, focusing on bacterial and fungal pathogens critical for AMR. Target is to encourage evidence generation for effective AMR policy translation www.sciencedirect.com/science/arti...

Congrsts. Great and important work

We share a lot of our ideas, code, datasets (that we spend years sanitizing) early. Often way before we release preprints. We do this so that others can use, build on, improve & even "beat" our approaches. But I want to say a few things about some simple expectations 1/

The Institute of Tropical Medicine in Antwerp launched the Armand Van Deun Scholarship Initiative in honour of his legacy. Armand was founding father of our short course Clinical Decision-Making for Drug-Resistant Tuberculosis (DR-TB) @ITM. Read more: www.itg.be/en/health-st...

Our work on immortal time bias "Illustrating the structures of bias from immortal time using directed acyclic graphs" led by Emma Guoyi Yang @yanggy_hku is out at International Journal of Epidemiology: doi.org/10.1093/ije/.... Brief thread:

⚠️ Bit of an alarm bell to MDR-TB regimen BPaL/M - resistance to constituent antibiotics developing and transmission of such strains already occurring #TBSky #IDSky @nejm.org www.nejm.org/doi/10.1056/...

Fake or flawed studies are polluting systematic reviews in medicine and other fields - but how do you spot them? For Nature, I report on efforts to create a short checklist of red flags, and on the automated integrity tools emerging to help. www.nature.com/articles/d41...

indianexpress.com/article/citi... Access to drugs continues to be a major concern for TB control. All the science in the world can't help if we can't get the drugs. #TBSky #endTB HT Ankita Upadhyay on twitter.

Rather happy with this one. We used a Lot Quality Assurance Sampling (LQAS) approach in surveillance of #AMR in #UTI in Indonesia. Working on this rapid surveillance approach for quite a while. doi.org/10.1093/aje/...

A hub-and-spoke approach to implementing #AntimicrobialStewardship programmes (ASPs) in Zambian hospitals improved the core elements of #AMS practice and modestly reduced antibiotic use over 1 year, offering insights for strengthening ASPs in Africa: https://buff.ly/4ghXvDP #JACAMRNews

We call for a more flexible One Health approach to prioritize localized AMR research in critical settings like hospitals and care facilities. This would address urgent human health needs while supporting broader integrative goals. www.bmj.com/content/386/...

Tuberculosis: a biosocial problem that requires biosocial solutions www.thelancet.com/journals/lan...

WHO-prequalified test is the same one that Cepheid claims to be selling “at cost”. But, in nearly 15 months since making that claim, Cepheid & its parent, Danaher, refuse to provide any evidence for it. The product is priced at 60% above a 2019 estimate of its cost + reasonable profit. 🧵

I'm advertising a PhD studentship (open to international students) on understanding how temperature may alter the ecology and evolution of AMR. Might suits someone with a microbiology/wet lab background who wants to expand into ecoevo. Or vice versa! But interest more important than experience.

Reproducing my viral thread from Twitter on why we should stop using the term "sub-Saharan Africa" Academics routinely use this term. For many years, I also used it without really thinking much about it or questioning its use. But it’s problematic and should be avoided. Here are the reasons:

Let’s start with a test: Think you can beat #misinformation? Try this #MisinformationSusceptibilityTest It only takes 2-5 minutes! ➡️ yourmist.streamlit.app #InfodemicManager #KCGH

We're thrilled to announce that we’ve begun preparing for the stable (1.0) releases of all packages in our ecosystem. Releases are expected early next year. If you’ve been using any of these packages, we would greatly value your feedback on the API: easystats.github.io/easystats/ #rstats #easystats

Global health can never be global because the global north is truly a “walled world” locking out everyone else www.forbes.com/sites/madhuk...

Next week we will be holding our first full East Midlands AMR Network conference. This is an expanding network of >100 researchers across 8 institutes and NHS Trusts in the region. If you want to follow the meeting, there is a new feed #EastMidsAMR. Wish us luck!

New paper Wondering how to select the appropriate tool to help assess diagnostic and prognostic models in systematic reviews? This new paper aims to help Open access 👉 www.jclinepi.com/article/S089...

This is good news

I had hoped for so many more posts from #WCE2024. Cape Town was too far for me. Any good stories? Thank you @pwgtennant.bsky.social for your posts. #episky

"...if translated into action..." www.who.int/news/item/26...

Here we go again...and not in a good way.

Important work and call-to-action. Thank you

Very nice work. Congrats

For the new science refugees here, I invite you to slip into the warm embrace of 20+ hours of free soothing lectures on scientific methods, a stats course for people who hate statistics, would rather be doing research or planning revolutions. Try the 1st vid - it's not what you expect. #stats 🧪

New Database for Reporting and Finding Replication Studies "We’re trying to make it easier for researchers to make their replication attempts public, because it’s often difficult to publish them, regardless of their outcome." #MetaSci 🧪

Looking forward to read it.

European #PublicHealth Association (EUPHA): Great to find my European professional association on Bluesky at @eupha.bsky.social And EUPHA Executive Director too: @charlottemar.bsky.social

1/2 Our new publication. Assessing clinical usefulness of adding non-specific symptoms of urinary tract infection to existing diagnostic algorithm for urinary tract infections in nursing home residents. doi:10.1017/ash.2024.345 tinyurl.com/4k3fdx74

How to address hurdles to access at a beach? Nice example from Ikaria, Greece. Well done.

Grading theses at the end of the academic year. My first recommendation: ban the use of the verb "utilize". It is horrible and not needed.

Teaching very large groups never has my preference. One perk though.....you get the movie theatre as a lecture hall. #Vrije-Unversiteit-Amsterdam